Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |